These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28324034)

  • 1. Anti-Müllerian Hormone and Ovarian Morphology in Women With Isolated Hypogonadotropic Hypogonadism/Kallmann Syndrome: Effects of Recombinant Human FSH.
    Bry-Gauillard H; Larrat-Ledoux F; Levaillant JM; Massin N; Maione L; Beau I; Binart N; Chanson P; Brailly-Tabard S; Hall JE; Young J
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1102-1111. PubMed ID: 28324034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
    Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
    J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pregnancy in a woman with idiopathic hypogonadotropic hypogonadism and low AMH: utility of ovarian reserve markers in IHH.
    Chan C; Liu K
    J Assist Reprod Genet; 2014 Oct; 31(10):1317-21. PubMed ID: 25113621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty.
    Coutant R; Biette-Demeneix E; Bouvattier C; Bouhours-Nouet N; Gatelais F; Dufresne S; Rouleau S; Lahlou N
    J Clin Endocrinol Metab; 2010 Dec; 95(12):5225-32. PubMed ID: 20826577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome.
    Zhang F; Liu XL; Rong N; Huang XW
    J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):70-73. PubMed ID: 28224431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions.
    Young J; Couzinet B; Chanson P; Brailly S; Loumaye E; Schaison G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3239-44. PubMed ID: 10999815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.
    Lie Fong S; Schipper I; de Jong FH; Themmen AP; Visser JA; Laven JS
    Fertil Steril; 2011 Aug; 96(2):459-63. PubMed ID: 21719005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH.
    Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM
    Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
    Alebic MŠ; Stojanovic N; Dewailly D
    Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian reserve parameters: a comparison between users and non-users of hormonal contraception.
    Bentzen JG; Forman JL; Pinborg A; Lidegaard Ø; Larsen EC; Friis-Hansen L; Johannsen TH; Nyboe Andersen A
    Reprod Biomed Online; 2012 Dec; 25(6):612-9. PubMed ID: 23069740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian luteinizing hormone priming preceding follicle-stimulating hormone stimulation: clinical and endocrine effects in women with long-term hypogonadotropic hypogonadism.
    Balasch J; Fábregues F; Carmona F; Casamitjana R; Tena-Sempere M
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2367-73. PubMed ID: 19366842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment.
    Nyström A; Mörse H; Nordlöf H; Wiebe K; Artman M; Øra I; Giwercman A; Henic E; Elfving M
    Acta Oncol; 2019 Feb; 58(2):218-224. PubMed ID: 30558460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of anti-müllerian hormone, follicle-stimulating hormone and antral follicle count on the outcome of ovarian stimulation in women following GnRH-antagonist protocol for IVF/ET.
    Tsakos E; Tolikas A; Daniilidis A; Asimakopoulos B
    Arch Gynecol Obstet; 2014 Dec; 290(6):1249-53. PubMed ID: 25001569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian Hormone and Ovarian Morphology in Women With Hypothalamic Hypogonadism.
    Alemyar A; van der Kooi ALF; Laven JSE
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32170295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antral follicle count and serum anti Müllerian hormone level for determination of gonadotropin dosing in in-vitro fertilization: randomized trial.
    Li HWR; Ko JKY; Lee VCY; Yung SSF; Lau EYL; Yeung WSB; Ho PC; Ng EHY
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):303-309. PubMed ID: 31325336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection.
    Arce JC; Andersen AN; Fernández-Sánchez M; Visnova H; Bosch E; García-Velasco JA; Barri P; de Sutter P; Klein BM; Fauser BC
    Fertil Steril; 2014 Dec; 102(6):1633-40.e5. PubMed ID: 25256937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the influence of three fibroid treatment options: supracervical hysterectomy, ulipristal acetate and uterine artery embolization on ovarian reserve - an observational study.
    Czuczwar P; Stepniak A; Milart P; Paszkowski T; Wozniak S
    J Ovarian Res; 2018 Jun; 11(1):45. PubMed ID: 29859107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian response markers lead to appropriate and effective use of corifollitropin alpha in assisted reproduction.
    La Marca A; D'Ippolito G
    Reprod Biomed Online; 2014 Feb; 28(2):183-90. PubMed ID: 24368127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between serum FSH, inhibin B and antral follicle count in the decline of serum AMH during the menstrual cycle in late reproductive age.
    Robertson DM; Lee CH; Baerwald A
    Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00172. PubMed ID: 33855196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.